Table 1.
Profiles of the patients with RA.
| No. | Age (years) | Sex | Duration of RA (years) | Class/stage† | DAS28-ESR | PSL (mg/day) | MTX (mg/week) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 4W | 8W | |||||||
| 1 | 57 | F | 18 | 2/4 | 5.01 | 3.16 | 2.93 | 2.5 | 6 |
| 2 | 93 | F | 11 | 2/4 | 5.32 | 3.52 | 3.00 | 3 | 6 |
| 3 | 91 | F | 20 | 1/2 | 3.65 | 2.38 | 2.66 | 2 | 6 |
| 4 | 51 | F | — | 2/3 | 5.82 | 2.13 | 2.06 | 5 | 5 |
| 5 | 55 | F | 21 | 2/4 | 4.62 | 2.66 | 3.27 | 0 | 2 |
| 6 | 68 | F | 9 | 1/4 | 4.05 | 4.05 | 1.66 | 4 | 0 |
| 7 | 63 | F | 27 | 3/4 | 4.93 | 3.63 | 2.98 | 5 | 4 |
†: Functional (class) and radiological (stage) classifications by Steinbrocker et al. [11].
DAS28: disease activity score 28 [12]. The DAS28 was evaluated at the time of serum collection. 0: before the first treatment, 4W: before the 2nd treatment, 8W: before the 3rd treatment.
PSL: dose of prednisolone, MTX: dose of methotrexate.